On Wednesday, Rapid Dose Therapeutics Corp.(CSE: DOSE, Forum) announced that its QuickStrip production equipment at Chemesis International Inc. (CSE: CSI)is fully installed, which enables the Company to see immediate revenue.
For more on this news, click here.
Recently, the Canadian life sciences Company began a clinical research trialwith the GI Research Institute and the University of British Columbia to study the effectiveness of providing daily doses of QuickStrip Vitamin B12 oral thin film strips to Inflammatory Bowel Disease patients who are vitamin B12 deficient.
FULL DISCLOSURE: Rapid Dose Therapeutics Corp. is a client of Stockhouse Publishing.